Home
» General World News » Prostate cancer: How new immunotherapy can help men with ‘very poor’ prognosis
Prostate cancer: How new immunotherapy can help men with ‘very poor’ prognosis
| 11/28/2019 | Posted by BusinessMediaguide.Com under General World News |
Comments off
|
PROSTATE CANCER is one of the most common forms of cancer in men, accounting for 44.4 percent of all cancers alongside lung, prostate and colorectal in 2018. A new immunotherapy drug has shown promise for prostate cancer sufferers in advanced stages of the disease. read more >>>
Source:: The Daily Express
